Access cutting-edge chemotherapy-induced peripheral neuropathy treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Ann Arbor location
Preparing your pre-screening questions…
Access chemotherapy-induced peripheral neuropathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chemotherapy-induced peripheral neuropathy treatment provided free
Check if you qualify for this chemotherapy-induced peripheral neuropathy clinical trial in Ann Arbor, MI
No-Cost Study Care
Local to Ann Arbor
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This clinical trial tests how well a type of non-invasive brain stimulation called transcranial direct current stimulation (tDCS) works to treat chemotherapy induced peripheral neuropathy (CIPN) in cancer survivors. CIPN is numbness, tingling, pain, and movement problems that can develop after chemotherapy as a result of changes to the nerves. A non-invasive form of brain stimulation called tDCS, applied to the area of the brain involved in sensation and movement, can temporarily improve the ability to detect vibration and temperature, as well as balance and walking, which may improve sensation and reduce pain in cancer survivors with CIPN.
Sponsor: University of Michigan Rogel Cancer Center
Yes, this clinical trial (NCT07673614) has an active research site in Ann Arbor, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chemotherapy-induced peripheral neuropathy treatment options in Ann Arbor, MI, this clinical trial (NCT07673614) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chemotherapy-induced peripheral neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chemotherapy-induced peripheral neuropathy clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Ann Arbor — not just this study.
Browse Pulmonary Embolism Trials in Ann Arbor →